LifeMD Lawsuit Filed Over Q2 2025 Financial Results, Investigation Underway

• LifeMD investors sue for securities fraud. • Lawsuit filed over Q2 2025 financial results. • Earnings disclosures prompt investigation. • Hagens Berman investigates potential securities law violations. • Investors with losses encouraged to submit claims. • Lead plaintiff deadline is October 27, 2025.

LifeMD Inc. (LFMD) is facing a securities fraud class action lawsuit following its Q2 2025 financial results. The lawsuit, styled Johnston v. LifeMD, Inc., et al., No. 1:25-cv-04761 (E.D.N.Y), seeks to represent investors who purchased LifeMD securities between May 7, 2025, and August 5, 2025 [1].

The lawsuit alleges that LifeMD made false and misleading statements while failing to disclose crucial information to investors. During its earnings call on May 6, 2025, LifeMD raised its full year 2025 revenue and adjusted EBITDA guidance, claiming to have created a competitive moat in virtual obesity care and that its RexMD brand was performing exceptionally well [1].

However, on August 5, 2025, LifeMD surprised investors with its Q2 2025 financial results, missing consensus GAAP EPS and revenue estimates and slashing its revenue and adjusted EBITDA guidance. The company attributed the underperformance to higher refund rates and elevated customer acquisition costs in the ED market [1].

Hagens Berman, a prominent shareholder rights firm, is investigating whether LifeMD may have recklessly guided on May 6, 2025, while its weight management was experiencing higher refund rates and RexMD was experiencing elevated acquisition costs [1]. The firm urges investors in LifeMD who suffered significant losses to submit their losses now [1].

The Rosen Law Firm has also filed a class action lawsuit on behalf of LifeMD investors, encouraging those who purchased securities during the class period to join the lawsuit [2]. The lead plaintiff deadline is October 27, 2025 [2].

Investors should consult with their financial advisors before taking any action. For more information, visit the respective law firms' websites or contact their legal teams.

References:
[1] https://www.globenewswire.com/news-release/2025/09/02/3142715/32716/en/LifeMD-Inc-LFMD-Hit-With-Securities-Class-Action-After-Shares-Crash-44-On-Q2-2025-Earnings-Surprise-Problems-With-Obesity-Care-and-RexMD-Hagens-Berman.html
[2] https://www.morningstar.com/news/pr-newswire/20250901dc62528/lfmd-investors-have-opportunity-to-lead-lifemd-inc-securities-fraud-lawsuit-first-filed-by-the-rosen-law-firm